There were 1,483 press releases posted in the last 24 hours and 442,021 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Brickell Biotech Announces Initiation of U.S. Phase 3 Program Evaluating Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image